Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aphthous stomatitis and its management.

H R Santis1

  • 1Department of Oral Pathology and Medicine, Tufts University School of Dental Medicine, Boston.

Current Opinion in Dentistry
|December 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A clinico-pathologic presentation. Congenital epulis of the newborn.

Journal of the Massachusetts Dental Society·1997
Same author

A clinico-pathologic presentation. Ranula.

Journal of the Massachusetts Dental Society·1996
Same author

A clinico-pathologic presentation. The diagnosis is nicotine stomatitis.

Journal of the Massachusetts Dental Society·1996
Same author

A clinico-pathologic presentation. Hereditary hypohidrotic ectodermal dysplasia, or HED.

Journal of the Massachusetts Dental Society·1996
Same author

A clinico-pathologic presentation. Orofacial angiomatosis.

Journal of the Massachusetts Dental Society·1996
Same author

A clinico-pathologic presentation. Melanotic neuroectodermal tumor of infancy.

Journal of the Massachusetts Dental Society·1995

Recurrent aphthous stomatitis is challenging to treat due to unknown causes. Recent research highlights thalidomide as a potential therapy for this condition.

Area of Science:

  • Oral Medicine
  • Dermatology

Background:

  • Recurrent aphthous stomatitis (RAS) presents significant clinical challenges.
  • The exact etiology and pathogenesis of RAS remain incompletely understood.

Purpose of the Study:

  • To briefly review the clinical features and etiology of RAS.
  • To discuss various therapeutic modalities for RAS.
  • To highlight recent literature on thalidomide treatment for RAS.

Main Methods:

  • Literature review of clinical features, etiology, and treatment of RAS.
  • Discussion of established and emerging therapeutic options.
  • Focus on recent studies concerning thalidomide.

Main Results:

  • RAS etiology and pathogenesis are not well-established, complicating treatment.

Related Experiment Videos

  • Multiple treatment options exist, including corticosteroids, antibiotics, and mouth rinses.
  • Thalidomide has emerged as a recent focus in RAS treatment literature.

    • Conclusions:

    • Effective treatment for recurrent aphthous stomatitis remains difficult due to unclear causes.
    • A range of therapies are available, with thalidomide showing recent promise in research.